glp 1 light headed The Risk of Vestibular Disorders with Semaglutide and Tirzepatide: Findings from a Large Real-World Cohort Does GLP-1 Make You Dizzy?

Shorter needles (e.g., 5mm or 6mm) are insufficient for reliable subcutaneous injection, while longer needles (10mm or more) risk penetrating intramuscular or neurovascular structures

Three studies lasted 12 weeks, five studies lasted 24 weeks, and one study lasted 16 weeks

McIntyre, MD, FRCPC, published in Psychiatric Times , shows: Depression Initial studies show reduced depressive symptoms in patients taking semaglutide or liraglutide

485,486,490 The bioavailability of oral L-carnitine in patients with CKD is unknown

Semaglutide GLP-1 injections operate by replicating the actions of a hormone known as glucagon-like peptide-1, or GLP-1, which has a specific influence on brain regions responsible for appetite and food consumption regulation